Table 6.
US7 score | |||||||
---|---|---|---|---|---|---|---|
Synovitis GS | Synovitis PD | Tenosynovitis GS | Tenosynovitis PD | US erosions | Total US scores | ||
Disease duration | r s | -0.150 | -0.089 | 0.101 | 0.007 | 0.535 * | 0.145 |
P | 0.529 | 0.709 | 0.671 | 0.976 | 0.015 * | 0.542 | |
DAS28 | r s | 0.024 | -0.265 | 0.175 | -0.239 | -0.077 | -0.059 |
P | 0.922 | 0.259 | 0.534 | 0.309 | 0.747 | 0.805 | |
HAQ score | r s | -0.210 | 0.005 | 0.057 | -0.013 | 0.334 | 0.077 |
P | 0.373 | 0.982 | 0.812 | 0.955 | 0.151 | 0.746 | |
PGA | r s | -0.349 | -0.111 | 0.208 | 0.321 | -0.082 | -0.172 |
P | 0.132 | 0.640 | 0.379 | 0.168 | 0.731 | 0.469 | |
Pain –VAS | r s | -0.349 | -0.111 | 0.208 | 0.321 | -0.082 | -0.172 |
P | 0.132 | 0.640 | 0.379 | 0.168 | 0.731 | 0.469 | |
ESR 1st hr | r s | 0.015 | -0.090 | -0.087 | 0.136 | -0.336 | -0.024 |
P | 0.951 | 0.707 | 0.717 | 0.569 | 0.147 | 0.919 | |
CRP | r s | -0.241 | -0.065 | -0.369 | -0.306 | -0.093 | -0.206 |
P | 0.305 | 0.784 | 0.110 | 0.189 | 0.695 | 0.385 | |
RF | r s | 0.176 | 0.365 | 0.525 * | 0.346 | 0.377 | 0.443 |
P | 0.459 | 0.114 | 0.017 * | 0.135 | 0.101 | 0.051 | |
ACPA | r s | 0.459 * | 0.627 * | 0.675 * | 0.554 * | 0.402 | 0.666 * |
P | 0.042 * | 0.003 * | 0.001 * | 0.011 * | 0.079 | 0.001 * | |
Serum OPN | r s | 0.323 | -0.003 | -0.092 | 0.169 | 0.179 | 0.342 |
P | 0.165 | 0.991 | 0.699 | 0.475 | 0.450 | 0.141 | |
Serum OPG | r s | 0.512 * | 0.323 | 0.160 | 0.136 | 0.138 | 0.509 * |
P | 0.021 * | 0.165 | 0.500 | 0.569 | 0.562 | 0.022 * |
rs: Spearman coefficient, *: Statistically significant at p ≤ 0.05
US7: 7-joint ultrasound score; GS: Grayscale; PD: power Doppler; DAS: disease activity score; HAQ: health assessment questionnaire; PGA: Patient global assessment; VAS: Visual Analogue Scale; ESR: erythrocyte sedimentation rate; CRP: c-reactive protein; RF: rheumatoid factor; ACPA: anti-citrullinated protein antibodies; OPN: Osteopontin; OPG: Osteoprotegerin